BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3126283)

  • 1. Immunohistologically definable light chain restriction in autoimmune disease.
    Jasani B
    J Pathol; 1988 Jan; 154(1):1-5. PubMed ID: 3126283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High incidence of free monoclonal lambda light chains in the sera of patients with Sjogren's syndrome.
    Moutsopoulos HM; Steinberg AD; Fauci AS; Lane HC; Papadopoulos NM
    J Immunol; 1983 Jun; 130(6):2663-5. PubMed ID: 6406594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome.
    Gottenberg JE; Aucouturier F; Goetz J; Sordet C; Jahn I; Busson M; Cayuela JM; Sibilia J; Mariette X
    Ann Rheum Dis; 2007 Jan; 66(1):23-7. PubMed ID: 16569685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-cell lymphoma and Sjögren's syndrome. Lymphoplasmacytic subvariant of small-cell lymphoma with IgA/kappa immunoglobulin surface markers.
    Askari AD; Laqui CC; Rassiga AL; Hogrefe WR; Laipply TC
    Arch Intern Med; 1985 May; 145(5):935-7. PubMed ID: 3922321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequency of light chain restriction in labial gland biopsies of Sjögren's syndrome detected by in situ hybridization.
    Jordan RC; Pringle JH; Speight PM
    J Pathol; 1995 Sep; 177(1):35-40. PubMed ID: 7472777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of serum IgM kappa monoclonicity in patients with Sjögren's syndrome with an increased proportion of kappa positive plasma cells infiltrating the labial minor salivary glands.
    Moutsopoulos HM; Tzioufas AG; Bai MK; Papadopoulos NM; Papadimitriou CS
    Ann Rheum Dis; 1990 Nov; 49(11):929-31. PubMed ID: 2124096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonamyloidotic monoclonal immunoglobulin deposits lack amyloid P component.
    Gallo G; Picken M; Frangione B; Buxbaum J
    Mod Pathol; 1988 Nov; 1(6):453-6. PubMed ID: 3146753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoproliferative disease in primary B-cell immunodeficiency. Lymphoplasmocytoid lymphoma or Sjögren's pseudo-lymphoma?
    Montecucco C; Chériè-Lignière EL; Rosso R; Riccardi A; Carnevale R; Caporali R; Gorini M
    Haematologica; 1986; 71(3):237-40. PubMed ID: 3093330
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma cells in the dermal infiltrate of mycosis fungoides are of polyclonal origin.
    Boehncke WH; Schulte-Rebbelmund H; Sterry W
    Acta Derm Venereol; 1989; 69(2):166-9. PubMed ID: 2564237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunofixation in agarose gel for the identification of monoclonal immunoglobulins].
    Potdevin F; Roncato M; Drupt F; Paris M; Leclerc M
    Ann Immunol (Paris); 1983; 134C(1):105-23. PubMed ID: 6407384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of several immunochemical approaches for the screening of alpha chain disease.
    Orr KB
    Diagn Immunol; 1983; 1(1):43-8. PubMed ID: 6437724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal kappa:lambda light chain ratio in circulating immune complexes as a marker for B cell activity in juvenile idiopathic arthritis.
    Low JM; Chauhan AK; Moore TL
    Scand J Immunol; 2007 Jan; 65(1):76-83. PubMed ID: 17212770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interstitial nephritis with infiltration of IgG-kappa positive plasma cells in a patient with Sjögren's syndrome.
    Pijpe J; Vissink A; Van der Wal JE; Kallenberg CG
    Rheumatology (Oxford); 2004 Jan; 43(1):108-10. PubMed ID: 14681564
    [No Abstract]   [Full Text] [Related]  

  • 14. Medical and technical usefulness of measurement of kappa and lambda immunoglobulin light chains in serum with an M-component.
    Lievens MM
    J Clin Chem Clin Biochem; 1989 Aug; 27(8):519-23. PubMed ID: 2509630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin kappa light chain gene alleles are not associated with primary Sjögren's syndrome.
    Downie-Doyle S; Lester S; Bardy P; Gordon T; Rischmueller M; Pile K
    Genes Immun; 2002 Oct; 3 Suppl 1():S63-5. PubMed ID: 12215905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential use of lambda L chain in lamin B autoantibodies.
    Reeves WH; Ali SA
    J Immunol; 1989 Dec; 143(11):3614-8. PubMed ID: 2511246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and distribution of B lineage cells in the domestic cat: analysis with monoclonal antibodies to cat mu-, gamma-, kappa-, and lambda-chains and heterologous anti-alpha antibodies.
    Klotz FW; Gathings WE; Cooper MD
    J Immunol; 1985 Jan; 134(1):95-100. PubMed ID: 3917286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celluar immunoglobulins in human gamma- and alpha-heavy chain diseases.
    Preud'homme JL; Brouet JC; Seligmann M
    Clin Exp Immunol; 1979 Aug; 37(2):283-91. PubMed ID: 115628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pertinence of kappa and lambda recombinant antibodies directed against thyroid peroxidase in thyroid autoimmune disease.
    Bresson D; Chardès T; Chapal N; Bès C; Cerutti M; Devauchelle G; Bouanani M; Mani JC; Péraldi-Roux S
    Hum Antibodies; 2001; 10(3-4):109-18. PubMed ID: 11847422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunonephelometric analysis of immunoglobulin light chains: agreement between the theoretical and experimental model. Assessment of the reference values of the kappa/lambda ratio and the heavy to light chain ratio].
    Chapuis-Cellier C; Cloppet H; Chazaud A; Coquelin H
    J Pharm Belg; 1996; 51(1):23-27. PubMed ID: 8882446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.